Outcomes of dexmedetomidine as adjuvant drug in patients undergoing videolaparoscopic cholecystectomy: A randomized and prospective clinical trial.
Gustavo Nascimento SilvaVirna Guedes BrandãoRossano FiorelliMarcelo Vaz PerezCarolina Ribeiro MelloDaniel NegriniKai-Uwe LevandrowskiRafael Bof MartinelliTatiana Pereira do Amaral Dos ReisPublished in: International journal of immunopathology and pharmacology (2023)
Immunomodulatory Effect of Dexmedetomidine as an Adjuvant Drug in Laparoscopic Cholecystectomies, NCT05489900, Registered 5 August 2022-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT05489900?term=NCT05489900&draw=2&rank=1.
Keyphrases
- clinical trial
- patients undergoing
- early stage
- cardiac surgery
- computed tomography
- preterm infants
- adverse drug
- robot assisted
- randomized controlled trial
- contrast enhanced
- dual energy
- magnetic resonance imaging
- study protocol
- magnetic resonance
- open label
- metabolic syndrome
- gestational age
- adipose tissue
- phase iii
- weight loss
- skeletal muscle
- electronic health record